2025
SJR Q3
JCR Q3 · 2,2
353 matched articles
SCIE
Journal detail
Coronary Artery Disease
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0954692814735830
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,455
- Quartile Q3
- H-Index 71
- Cites/doc 1,75
- Docs (3y) 367
- Cites (3y) 530
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,2
- 5Y JIF 1,9
- JCI 0,44
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q3
- Medicine (miscellaneous) Q3
Areas
- Medicine
WoS categories
- Cardiac & Cardiovascular System
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,455 | 2,2 | 1,9 | 0,44 | Q3 | 71 |
| 2024 | Q3 | Q3 | 0,46 | 2 | 1,7 | 0,45 | Q3 | 70 |
| 2023 | Q3 | Q3 | 0,384 | 1,5 | 1,4 | 0,43 | Q3 | 70 |
| 2022 | Q3 | Q4 | 0,419 | 1,8 | 1,7 | 0,43 | Q3 | 70 |
| 2021 | Q3 | Q4 | 0,395 | 1,7 | 1,7 | 0,35 | Q3 | 70 |
| 2020 | Q3 | Q4 | 0,504 | 1,4 | 1,6 | 0,33 | Q3 | 70 |
| 2019 | Q2 | Q4 | 0,524 | 1,3 | 1,4 | 0,37 | Q3 | 70 |
| 2018 | — | Q4 | — | 1,6 | 1,6 | 0,46 | Q3 | — |
| 2017 | Q2 | Q3 | 0,705 | 1,7 | 1,6 | 0,45 | Q2 | 70 |
| 2016 | Q2 | Q3 | 0,731 | 1,8 | 1,8 | — | — | 70 |
| 2015 | Q2 | Q3 | 0,751 | 1,6 | 1,5 | — | — | 70 |
| 2014 | Q2 | Q3 | 0,697 | 1,5 | 1,4 | — | — | 70 |
| 2013 | Q2 | Q4 | 0,602 | 1,3 | 1,3 | — | — | 70 |
| 2012 | Q2 | Q3 | 0,539 | 1,1 | 1,4 | — | — | 70 |
| 2011 | Q2 | Q4 | 0,718 | 1,2 | 1,5 | — | — | 70 |
| 2010 | Q1 | Q3 | 0,817 | 1,7 | 1,7 | — | — | 70 |
| 2009 | — | Q3 | — | 1,5 | 1,5 | — | — | — |
| 2008 | — | Q4 | — | 1,3 | 1,7 | — | — | — |
| 2007 | — | Q3 | — | 1,6 | 1,6 | — | — | — |
| 2006 | — | Q3 | — | 1,5 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | Q3 | — | 1,5 | — | — | — | — |
| 2003 | — | Q3 | — | 1,3 | — | — | — | — |
| 2002 | — | Q3 | — | 1,2 | — | — | — | — |
| 2001 | — | Q3 | — | 1,1 | — | — | — | — |
| 2000 | — | Q3 | — | 1 | — | — | — | — |
| 1999 | — | Q3 | — | 0,9 | — | — | — | — |
| 1998 | — | Q3 | — | 0,9 | — | — | — | — |
| 1997 | — | Q3 | — | 0,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 132/237 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 125/231 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q3 | 146/222 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 112/143 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 126/143 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 133/142 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 116/138 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | Q3 | 104/136 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 86/128 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 84/126 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 83/124 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 79/123 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 52/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 51/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 54/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 40/68 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 42/61 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 45/56 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/54 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 32/52 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/51 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/51 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/52 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 30/52 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/50 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 30/45 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 32/44 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 24/39 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 25/38 |